Comparing SR 95 → SR 684 — ALS AWARENESS MONTH

Struck = only in SR 95 · added = only in SR 684.

Previous
Latest
Bill Text - SR-95 skip to content home accessibility FAQ feedback sitemap login x Quick Search:
*LRB10421227MST35817r* SR0684 LRB104 21227 MST 35817 r SENATE RESOLUTION WHEREAS, Amyotrophic lateral sclerosis (ALS), known by many as Lou Gehrig's disease, is a progressive fatal neurodegenerative disease in which a person's brain loses connection with the muscles, slowly taking away their ability to walk, talk, eat, and eventually breathe;
Bill Number Bill Keyword Home Bill Information California Law Publications Other Resources My Subscriptions My Favorites Bill Information >> Bill Search >> Text Bill Text PDF2 Bill PDF |Add To My Favorites |Track Bill | Version:
and WHEREAS, ALS has no cure, and every 90 minutes, someone is diagnosed with ALS and someone passes away from ALS;
05/12/26 - Enrolled 04/21/26 - Amended Senate 04/06/26 - Introduced SR-95 (2025-2026) Text >> Votes >> History >> Bill Analysis >> Today's Law As Amended >> Compare Versions >> Status >> Comments To Author >> Track Bill >> Add To My Favorites >> SHARE THIS:
on average, patients diagnosed with ALS only survive two to five years from the time of diagnosis;
SR95:v97#DOCUMENTBill Start Enrolled  May 12, 2026 Passed  IN  Senate  May 11, 2026 Amended  IN  Senate  April 21, 2026 CALIFORNIA LEGISLATURE— 2025–2026 REGULAR SESSION Senate Resolution No.
and WHEREAS, People who have served in the military are more likely to develop ALS and die from the disease than those with no history of military service;
95Introduced by Senator Niello(Coauthors:
and WHEREAS, Securing access to new therapies, durable medical equipment, and communication technologies is of vital importance to people living with ALS;
Senators Becker, Caballero, Choi, Dahle, Ochoa Bogh, Richardson, Seyarto, Strickland, Valladares, and Wahab)April 06, 2026Relative to Amyotrophic Lateral Sclerosis Awareness Month.
and WHEREAS, Clinical trials play a pivotal role in evaluating new treatments, enhancing quality of life, and fostering assistive technologies for those living with ALS;
LEGISLATIVE COUNSEL'S DIGESTSR 95, Niello.
and WHEREAS, This year marks the 12th anniversary of the Ice SR0684 -2- LRB104 21227 MST 35817 r Bucket Challenge, and it is fitting to make a renewed commitment to galvanize public awareness and support funding leading to significant investments in ALS research;
Digest KeyBill TextWHEREAS, Amyotrophic lateral sclerosis (ALS), also commonly referred to as Lou Gehrig’s disease, is a progressive fatal neurodegenerative disease in which a person’s brain loses connection with their muscles, slowly reducing a person’s ability to walk, talk, eat, and eventually breathe;
and WHEREAS, The ALS Association, as the largest philanthropic funder of ALS research globally, has committed over $154 million to support more than 550 projects across the United States and 18 other countries;
andWHEREAS, Thousands of new ALS cases are reported every year, and estimates show that every 90 minutes someone is diagnosed with ALS and someone passes away from ALS;
and WHEREAS, The ALS community and researchers remain unwaveringly committed to accelerating the pace of discovery, fueled by the hope that one day ALS will be a livable disease for everyone, everywhere;
andWHEREAS, On average, patients diagnosed with ALS survive only two to five years from the time of diagnosis;
and WHEREAS, Observing ALS Awareness Month increases the public's awareness of the dire circumstances faced by people living with ALS, acknowledges the terrible impact this disease has, not only on the person but on his or her family and the community, and recognizes the research being done to eradicate this disease;
andWHEREAS, The exact causes of ALS are unknown and there is no known cure for ALS;
therefore, be it RESOLVED, BY THE SENATE OF THE ONE HUNDRED FOURTH GENERAL ASSEMBLY OF THE STATE OF ILLINOIS, that we declare May 2026 as ALS Awareness Month and urge all Americans to join in supporting ALS research, advocating for increased funding, and standing in solidarity with those affected by this relentless SR0684 -3- LRB104 21227 MST 35817 r disease.
andWHEREAS, People who have served in the military are more likely to develop ALS and die from the disease than those with no history of military service;
andWHEREAS, Securing access to new therapies, durable medical equipment, and communication technologies is of vital importance to people living with ALS;
andWHEREAS, Clinical trials play a pivotal role in evaluating new treatments, enhancing quality of life, and fostering assistive technologies for those living with ALS;
andWHEREAS, Amyotrophic Lateral Sclerosis Awareness Month provides an opportunity to increase public awareness of the dire circumstances of people living with ALS, acknowledge the terrible impact this disease has on those individuals and their families, and support research to eradicate this disease;
now, therefore, be itResolved by the Senate of the State of California, That the Senate hereby proclaims the month of May 2026 as Amyotrophic Lateral Sclerosis Awareness Month, and calls upon all Americans to join in supporting ALS research, advocating for increased funding, and standing in solidarity with those affected by this relentless disease;
and be it furtherResolved, That the Secretary of the Senate transmit copies of this resolution to the author for appropriate distribution.